Indoco Remedies Limited (NSE:INDOCO)
219.55
+2.48 (1.14%)
Apr 17, 2026, 3:29 PM IST
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 20.27 billion as of April 17, 2026. Its market cap has decreased by -9.61% in one year.
Market Cap
20.27B
Enterprise Value
30.00B
Revenue
17.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
219.55
Market Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 20.27B, an increase of 334.87%. That is a compound annual growth rate of 7.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 20.27B | -6.36% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 48.03B |
| Innova Captab | 42.48B |
| RPG Life Sciences | 33.48B |
| Orchid Pharma | 28.88B |
| Solara Active Pharma Sciences | 24.04B |
| Windlas Biotech | 18.27B |
| Beta Drugs | 13.89B |
| Sakar Healthcare | 13.21B |